Wilson Sonsini Releases Life Science Report

The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley. For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare. Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.

Wilson Sonsini Life sciences report

In their January 2024 Life Science Report, downloadable in PDF format, the issue features articles and interviews on:

  • Business Advisory Practice supporting Nervosave Therapeutics’ U.S. expansion
  • USPTO’s forthcoming guidance on AI innovation protection; 
  • Option pool sizes for life sciences companies
  • Life sciences venture financings for clients
  • Congress’s attempts to improve medical diagnostics patent eligibility
  • A client interview with SonoThera CEO Kenneth Greenberg
  • The DOJ’s incentives for life sciences companies to self-disclose misconduct
  • Q&A with Ed Shenkan on decreasing risk from medical device concept to commercialization
  • Recent NextGen VC Forums hosted in conjunction with LaunchBio
  • Introduction to the NextGen VC Podcast hosted by WSGR partners Michael Hostetler and Jen Fang

You can download the full report here.

If you haven’t already, subscribe to the NextGen VC podcast, available on all major podcast platforms.



  • Topics

  • Reset